Abstract According to literature data, self-renewing, multipotent, and clonogenic cardiac c-Kit
Introduction
Dividing cardiomyocytes discovered in the human heart have challenged the paradigm of a myocardium built from terminally differentiated cells unable to proliferate [14] . Extensive research has led to identification of stem/progenitor cells in the heart. Several types of cells have been distinguished that show stem cell characteristics. Furthermore, many researches have performed studies with bone marrow-derived progenitor cells and circulating progenitor cells concerning its impact to postinfarction heart function. There have observed inconsistent effects on LV remodeling [9, 12, 20, 24] .
One of stem/progenitor cells in the heart are cells with c-Kit receptor (CD117 or SCFR-stem cell factor receptor) on the surface. c-Kit
? cells proliferate both symmetrically and asymmetrically. Some of them demonstrate the expression of transcription factors typical of endothelial cells, vascular smooth muscle cells, or cardiomyocytes [3] . The c-Kit receptor is also found on the surface of hematopoietic stem cells as well as progenitor and mast cells, certain dendritic cells, and also on melanocytes [8] . Immunohistochemical analysis showed that more than 85 % of c-Kit According to Bearzi et al. c-Kit ? cells features seem typical of stem cells: they are self-renewing, clonogenic, and multipotent (able to differentiate into endothelial cells, smooth muscle cells and cardiomyocytes) [3] . Certain in vivo trial results indicate the capability of c-Kit
? cells to form a functional myocardium, and improve postmyocardial infarction function [3] . The results of this study laid foundation for Phase I randomized clinical trial Stem Cell Infusion in Patients with Ischemic cardiOmyopathy (SCI-PIO), in which patients with heart failure resulting from ischaemic heart disease were treated with intracoronary infusion of autologous c-Kit ? cells proliferated under in vitro conditions. Preliminary results suggested improved contractile function of the left ventricle as well as reduced postinfarction scar size. There have been no deaths, cardiac cancer, or cardiac complications requiring hospitalization. This indicates that the transplantation of c-Kit
? cells is a safe method [5] . However, in recent years, some papers [16, 25] [21] . The correctness of this distinction has also been confirmed by vascular endothelial stem cell research, in which a population of rare Lin -CD31 ? CD105 ? Sca1 ? CD117 ? cells was described. The latter are capable of self-renewal and relevant to the process of angiogenesis [8] . Hematopoietic origin of these cells was excluded by research performed on both cardiac progenitor c-Kit cells and vascular stem cells [2, 8] .
According to Gambini et al. c-Kit ? cells possess CD105 and CD29 markers which are typical of mesenchymal stem cells [11] . These cells can differentiate into typical MSC progeny lines, such as osteoblasts and adipocytes. However, their ability to differentiate is much lower when compared with bone marrow-derived MSC control cells [10, 11] .
The aim of our research was to identify c-Kit ? cells in myocardial tissue and in cell cultures derived from explanted hearts obtained from recipients during transplantation.
Materials and methods

Ethical statements
This study was conducted according to the principles expressed in the declaration of Helsinki and was approved by the institutional review board.
Patients and tissue samples
The material used in the study was explanted hearts removed during heart transplant surgery. Tissue fragments were harvested from right ventricle (RV), left ventricle (LV), intraventricular septum (IVS), atrium (A) and apex (APX). The material was collected from 19 adults and 7 children. The following general information was obtained about the patients: sex, age, and cardiovascular history. The collected material was used for immunohistochemical analysis and to establish in vitro cell cultures.
Immunohistochemical analysis
The harvested material was fixed using 4 % paraformaldehyde and embedded in paraffin. Paraffin sections (5 lm) were obtained and incubated for 1 h in 4 % FBS (Foetal Bovine Serum, Gibco) to minimize nonspecific antibody binding. Next the sections were incubated with primary antibodies: anti-c-Kit (Dako), anti-Mast Cell Tryptase (Abcam) and, subsequently, with secondary antibodies conjugated with FITC (Dako) or Texas Red (Vector Laboratories). To reduce autofluorescence the tissues were incubated in Sudan Black B (Sigma) solution. Sections were then mounted using Mounting Medium with DAPI (to stain cell nuclei) (Vector Laboratories). The immunohistochemical sections were observed using a Zeiss LSM710 confocal microscope.
Isolation and cell culture
Tissue material derived from RV, LV, IVS, A, and APX was cut into 1-3 mm 2 pieces, washed with PBS -(Mg 2? , Ca 2? -free phosphate buffered saline) to remove blood and fat tissue. Subsequently, the material was digested with collagenase IV (1 mg/ml, Sigma) for 10 min, and three times with 0.25 % trypsin (Sigma) for 5 min. The partially digested tissue fragments were incubated (37°C, 95 % air and 5 % CO 2 ) in IMDM medium (Sigma) supplemented with 20 % FBS, L-glutamine (Sigma), b-mercaptoethanol (Sigma), and antibiotics (penicillin and streptomycin, Sigma) and using culture plates coated with fibronectin (20 lg/ml). The medium was changed every 2 or 3 days for 3 weeks.
Human Umbilical Vein Endothelial Cells (HUVEC, ATCC) were grown (37°C, 95 % air and 5 % CO 2 ) in RPMI 1640 medium supplemented with 20 % FBS, heparin (100 lg/ml) and bFGF (50 ng/ml, BD Biosciences) and using culture flasks covered with 0.1 % gelatin. The medium was changed every 2 or 3 days.
Phenotypic analysis
Upon reaching 70 % confluence, cells obtained from tissue fragment cultures were treated with 0.02 % EDTA solution and 0.05 % trypsin. A single cell suspension was obtained, and was next incubated (30 min at 4°C) with suitable combinations of the following monoclonal antibodies against human antigens or isotype-matched control antibodies: c-Kit-APC, CD105-PE (eBioscience); CD31-FITC, CD34-FITC, CD45-APC-Cy7, CD33-PE, KDR-PE, Lin-FITC (BD Bioscience); finally analysed using a BD FACSCanto cytometer.
Statistical analysis
Statistical significance of differences between groups was evaluated by ANOVA (analysis of variance). P \ 0.05 was considered statistically significant.
Results
The experimental flow chart for proceeding with the explanted material is shown in Fig. 1 . Tissue fragments were used to establish primary cardiac cell culture. The remaining material was fixed for immunohistochemical analysis.
Identification of c-Kit
? cells in the myocardial tissue
A few c-Kit
? tryptase -cells were observed in the human cardiac tissue sections (Fig. 2a) . Most of the c-Kit
? cells contained tryptase--an enzyme specific to mast cells (Fig. 2b ). There were no differences in amount of c-Kit ? tryptase -cells in the material derived from adults and children.
Phenotypic analysis of cell cultures
Cell culture was established for 95 (84.1 %) of 113 tissue fragments obtained from different cardiac regions (Fig. 3B1) , past cardiovascular disorders (Fig. 3B2) , nor the recipient's gender (Fig. 3B3 ).
An exception to this was the cultures obtained from part of the material derived from children. In cultures derived from three pediatric subjects, c-Kit ? percentage ranged from 11 to 24 % (Table 2 ). These cells had neither CD45 hematopoietic cell marker, nor lineage markers (Lin) or CD33 mast cell marker (Fig. 4b) . c-Kit
? cells obtained from in vitro culture did not possess KDR surface marker of progenitor endothelial cells (Fig. 5a) . However, CD105 mesenchymal cell marker was identified on all c-Kit ? cells (Fig. 4a) . Furthermore, majority of cells showed also CD31 and CD34 endothelial cell markers (83.7 ± 8.6 and 75.7 ± 11.4 %, respectively). 
Discussion
Since c-Kit ? Lin -cells, considered to be resident cardiac stem cells, were discovered in human heart muscle [3] numerous research papers have focused on identification, in vitro characterization and potential applications of stem cells in the regeneration of damaged myocardium [6, 13, 15, 19] .
Our phenotypic analysis of cell cultures grown from cardiac fragments showed that the main population consists of cells with CD105 and CD90 mesenchymal antigens. The cardiac cell culture obtained appeared immunophenotypically similar to that described by Davis et al. [7] . The culture included a small population of c-Kit ? cells (\1 %). Data found in the literature indicate a relationship between the number of c-Kit
? cells and their location in the heart [13, 19] . Both immunohistochemical analyses [17] and in vitro cultures derived from the right atrium [13] suggest that it is a source of greatest numbers of c-Kit ? cells. However, our data do not support this observation. Similar levels of c-Kit ? cells, not exceeding 1 % (0.7-0.9 %), were observed in cell cultures derived from different cardiac fragments of adult individuals. Itzhaki-Alfia et al. found a greater number of c-Kit ? cells in cultures grown from women's hearts [13] . Our data do not support this observation neither. Some studies have indicated an increased number of c-Kit
? cells in patients with acute cardiac failure [10, 15, 23] . Nevertheless, our research did not find past cardiovascular diseases to affect the number of c-Kit
? cells in cardiac cell culture. Our observations are consistent with the data provided by Aghila Rani et al. [1] . However, we had at our disposal no control tissue from healthy subjects, the characteristics of which would allow us in determining increased numbers of c-Kit
? cells in connection with advanced stage of cardiac disease.
In tissue cultures derived from pediatric material (children aged 3-14), c-Kit ? cells ranged between 1 and 1.9 % of total number of cells with the exception of three children (11.7-24 cells from biopsy specimens derived from failed hearts, after ca. 40 days of in vitro culture [6] . In small animals, within ca. 7 days from myocardial infarction, inflammation recedes resulting in diminished number of factors involved in the chemotaxis of the cells to the site of injury, factors affecting differentiation and cell's survival [22] . Therefore, long culture time to obtain adequate numbers of c-Kit ? cells identified in the cardiac tissue possess a CD45 marker indicating their hematopoietic origin. Additional staining for tryptase (a specific mast cell marker) confirmed the presence of these cells [19] . Increased number of mast cells in the damaged heart corresponds to greater number of c-Kit ? cells [18] . Lack of additional staining for mast cells' presence can overrate the number of cells referred to ? cells to differentiate into cardiomyocytes, both in vitro and after transplantation to the damaged myocardium, has been challenged [25] . We did not provide any evidences standing for or against acquisition by c-Kit
? cell ''cardiac like'' phenotype. In our study, in descriptive manner, we characterized c-Kit
? cells as cells displaying mesenchymal stem cells features with mostly endothelial specification. More convincing study need to be done to confirm their ability to differentiate into cardiomyocytes. At present, it is believed that for the therapeutic effect observed after implanting cells to the postinfarction myocardium, responsible are factors secreted by these cells (the so-called paracrine effect). According to Tang et al. [22] direct regeneration of postinfarction heart by exogenous c-Kit
? cells is poor. However, the observed improvement of the structure and function of the left ventricle is rather mediated by a paracrine effect of cytokines produced by the implanted cells. These cytokines stimulate endogenous c-Kit ? cells. It is supposed that this effect can be maintained even after elimination all of implanted c-Kit ? cells.
Limitations
We are aware of the obvious limitation of our study. The material was collected from patients of different age, gender and cardiovascular disease. This variables might have impact on the obtained cell culture. The phenotype of cultured cells is also strongly influenced by in vitro conditions. This plasticity may cause that cells will acquire or lose characteristic antigens. Cells description based on the presence of surface markers is a phenomenal study. We can only observe cells in exact time and conditions. Thus, in vitro culture will not reflect phenotype of cells in vivo.
